X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (123) 123
index medicus (97) 97
male (87) 87
female (85) 85
genetics & heredity (49) 49
adolescent (47) 47
adult (46) 46
child (44) 44
enzyme replacement therapy (41) 41
taiwan (40) 40
mutation (36) 36
child, preschool (32) 32
infant, newborn (32) 32
pediatrics (31) 31
enzymes (28) 28
children (26) 26
fabry disease (25) 25
medicine (25) 25
medicine, research & experimental (25) 25
infant (24) 24
prevalence (24) 24
middle aged (23) 23
newborn screening (22) 22
phenotype (22) 22
young adult (22) 22
analysis (20) 20
diagnosis (19) 19
fabry disease - genetics (19) 19
genetic aspects (19) 19
identification (17) 17
medical colleges (17) 17
disease (16) 16
endocrinology & metabolism (16) 16
internal medicine (16) 16
mucopolysaccharidosis (16) 16
dna mutational analysis (15) 15
gene (15) 15
medicine, general & internal (15) 15
research (15) 15
retrospective studies (15) 15
infants (14) 14
medical screening (14) 14
aged (13) 13
mutation, missense (13) 13
alpha-galactosidase (12) 12
care and treatment (12) 12
taiwan - epidemiology (12) 12
alpha-galactosidase - genetics (11) 11
genetic research (11) 11
mutations (11) 11
oral (11) 11
part 4 (11) 11
part 4: oral/poster (11) 11
poster (11) 11
treatment outcome (11) 11
base sequence (10) 10
echocardiography (10) 10
fabry disease - diagnosis (10) 10
genetics (10) 10
genotype (10) 10
patients (10) 10
atypical variant (9) 9
biochemistry & molecular biology (9) 9
biomarkers - blood (9) 9
cardiomyopathy (9) 9
clinical neurology (9) 9
codon - genetics (9) 9
females (9) 9
medical research (9) 9
neonatal screening (9) 9
age (8) 8
alpha-glucosidases - blood (8) 8
asian continental ancestry group - genetics (8) 8
biopharmaceutics (8) 8
chinese (8) 8
fabry disease - enzymology (8) 8
glycogen storage disease type ii - genetics (8) 8
medicine, experimental (8) 8
mortality (8) 8
pedigree (8) 8
polymerase chain reaction (8) 8
tandem mass spectrometry (8) 8
time factors (8) 8
alpha-galactosidase - blood (7) 7
alpha-glucosidases - deficiency (7) 7
alpha-glucosidases - genetics (7) 7
electrocardiography (7) 7
globotriaosylceramide (7) 7
glycosaminoglycans (7) 7
growth (7) 7
heterozygote (7) 7
homozygote (7) 7
hospitals (7) 7
inborn-errors (7) 7
males (7) 7
mass spectrometry (7) 7
medicine & public health (7) 7
metabolism (7) 7
phenylketonuria (7) 7
point mutation (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Genetics in Medicine, ISSN 1098-3600, 2019, Volume 21, Issue 8, pp. 1892 - 1893
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 12/2016, Volume 68, Issue 23, pp. 2554 - 2563
Journal Article
Journal Article
Circulation: Cardiovascular Genetics, ISSN 0016-6731, 10/2009, Volume 2, Issue 5, pp. 450 - 456
Journal Article
by Chu, TH and Chien, YH and Lin, HY and Liao, HC and Ho, HJ and Lai, CJ and Chiang, CC and Lin, NC and Yang, CF and Hwu, WL and Lee, NC and Lin, SP and Liu, CS and Hu, RH and Ho, MC and Niu, DM
ORPHANET JOURNAL OF RARE DISEASES, ISSN 1750-1172, 04/2019, Volume 14, Issue 1, pp. 73 - 10
Journal Article
Orphanet Journal of Rare Diseases, ISSN 1750-1172, 06/2018, Volume 13, Issue 1, pp. 89 - 10
Background: Mucopolysaccharidosis type II (MPS II) is the most frequently occurring MPS in Taiwan, with an incidence of 2.05 per 100,000 live male births, but... 
Hernia repair | Hunter syndrome | Causes of death | Surgery | Diagnosis | Lysosomal storage disease | Survival | Symptoms | MEDICINE, RESEARCH & EXPERIMENTAL | FORM | DEATH | PREVALENCE | NATURAL-HISTORY | IDURSULFASE | GROWTH | GENETICS & HEREDITY | ENZYME REPLACEMENT THERAPY | AGE | Surveys | Hernia | Mucopolysaccharidosis | Patient outcomes | Enzymes | Demography | Cognitive ability | Births | Family medical history | Patients | Age | Data bases
Journal Article
Pediatric Pulmonology, ISSN 8755-6863, 03/2014, Volume 49, Issue 3, pp. 277 - 284
Background The mucopolysaccharidoses (MPS) comprise a group of inherited lysosomal storage disorders characterized by deficiencies in enzymes catalyzing the... 
glycosaminoglycans | pulmonary function | enzyme replacement therapy | spirometry | mucopolysaccharidoses | MORTALITY | LARONIDASE | EQUATIONS | CHINESE CHILDREN | HONG-KONG | REFERENCE VALUES | RESPIRATORY SYSTEM | PEDIATRICS | Spirometry | Age Factors | Mucopolysaccharidosis IV - complications | Humans | Mucopolysaccharidosis I - physiopathology | Mucopolysaccharidosis VI - complications | Male | Mucopolysaccharidosis III - drug therapy | Lung Diseases - etiology | Forced Expiratory Volume | Young Adult | Mucopolysaccharidosis II - physiopathology | Adult | Female | Mucopolysaccharidoses - complications | Mucopolysaccharidosis VI - drug therapy | Child | Mucopolysaccharidosis VI - physiopathology | Mucopolysaccharidoses - drug therapy | Severity of Illness Index | Mucopolysaccharidoses - physiopathology | Mucopolysaccharidosis III - physiopathology | Treatment Outcome | Lung - physiopathology | Mucopolysaccharidosis IV - drug therapy | Disease Progression | Mucopolysaccharidosis I - complications | Lung Diseases, Obstructive - physiopathology | Mucopolysaccharidosis III - complications | Enzyme Replacement Therapy - methods | Mucopolysaccharidosis II - complications | Mucopolysaccharidosis IV - physiopathology | Mucopolysaccharidosis II - drug therapy | Mucopolysaccharidosis I - drug therapy | Vital Capacity - physiology | Adolescent | Lung Diseases, Obstructive - etiology | Lung Diseases - physiopathology | Respiratory Function Tests | Peak Expiratory Flow Rate | Maximal Midexpiratory Flow Rate | Enzymes | Respiratory tract diseases | Care and treatment | Mucopolysaccharidosis | Glycosaminoglycans | Chemical properties
Journal Article